In osteosarcoma, there is limited evidence, but a study has correlated the altered expression of N-cadherin, due to a modulation of the sialyltransferase ST6Gal I activity to increased motility and invasiveness of osteosarcoma cells. Here, ST6GAL1 is linked to osteosarcoma.